PJSIMP
BMRN icon

P.J. Schmidt Investment Management (PJS)’s BioMarin Pharmaceuticals BMRN Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,216
Closed -$248K – 173
2021
Q2 		$248K Hold
3,216
– – 0.05% 160
2021
Q1 		$258K Buy
3,216
+72
+2% +$5.88K 0.05% 152
2020
Q4 		$260K Sell
3,144
-164
-5% -$13K 0.06% 141
2020
Q3 		$252K Sell
3,308
-23
-0.7% -$2.33K 0.06% 131
2020
Q2 		$411K Buy
3,331
+85
+3% +$8.45K 0.12% 88
2020
Q1 		$274K Buy
3,246
+140
+5% +$12.1K 0.1% 100
2019
Q4 		$263K Sell
3,106
-1,453
-32% -$110K 0.07% 125
2019
Q3 		$307K Sell
4,559
-1,408
-24% -$108K 0.09% 115
2019
Q2 		$511K Sell
5,967
-416
-7% -$35.6K 0.15% 90
2019
Q1 		$567K Buy
6,383
+50
+0.8% +$4.63K 0.17% 90
2018
Q4 		$539K Buy
6,333
+480
+8% +$45.7K 0.18% 88
2018
Q3 		$568K Hold
5,853
– – 0.16% 95
2018
Q2 		$551K Buy
5,853
+45
+0.8% +$3.94K 0.16% 93
2018
Q1 		$471K Buy
5,808
+2,335
+67% +$200K 0.14% 94
2017
Q4 		$310K Buy
+3,473
New +$302K 0.09% 109

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s BMRN Position: Q3 2021 in Review

P.J. Schmidt Investment Management (PJS) sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2021, closing a stake of 3,216 shares — an estimated $248K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in BMRN in Q4 2017 and held it in 15 quarters. The position peaked at $568K in Q3 2018. 511 funds tracked by Wall St. Rank hold BMRN as of Q3 2021.

  • P.J. Schmidt Investment Management (PJS) reported no remaining BioMarin Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • P.J. Schmidt Investment Management (PJS) sold 3,216 BioMarin Pharmaceuticals shares in Q3 2021, an estimated $248K.
  • P.J. Schmidt Investment Management (PJS) first reported a position in BioMarin Pharmaceuticals in Q4 2017 and held it in 15 quarters.
  • P.J. Schmidt Investment Management (PJS)'s BioMarin Pharmaceuticals position peaked at $568K in Q3 2018.
  • 511 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2021.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q3 2021, filed 27 Oct 2021.